Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence

Annals of Diagnostic Pathology

Volumn 18, Issue 2, 2014, Pages 49-52

  Hu, Zhihong ^a   Mudaliar, Kumaran ^a   Quek, Marcus L ^a   Paner, Gladell P ^b   Barkan, Güliz A ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Lamina propria; pT1; Recurrence; Resection; TURBT; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER SURGERY; CANCER DIAGNOSIS; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; CYSTECTOMY; DISEASE DURATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAMINA PROPRIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TRANSURETHRAL RESECTION OF BLADDER TUMOR; TUMOR INVASION; TUMOR RECURRENCE; TUMOR VOLUME; VERY ELDERLY; VISCERAL METASTASIS;

LAMINA PROPRIA; PT1; RECURRENCE; RESECTION; TURBT; UROTHELIAL CARCINOMA;

AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA; FEMALE; HUMANS; ILLINOIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84896390960     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2013.11.002     Document Type: Article

References (26)

1. M.S. Soloway Intravesical therapy for bladder cancer Urol Clin N Am 15 1988 661 669.
2. M.C. Hall, S.S. Chang, and G. Dalbagni et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update J Urol 178 2007 2314 2330.
3. K.G. Nepple, and M.A. O'Donnell The optimal management of T1 high-grade bladder cancer Can Urol Assoc J 3 2009 S188 S192.
4. J. Flamm, H. Kiesswetter, and S. Burkert Cystectomy or transurethral resection in the treatment of bladder carcinoma Z Urol Nephrol 75 1982 729 737.
5. R.J. Sylvester, A.P. van der Meijden, and W. Oosterlinck et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 465 466 [discussion 475-467].
6. K.T. Mai, G. Elmontaser, D.G. Perkins, H.M. Yazdi, W.A. Stinson, and A. Thijssen Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma BJU Int 94 2004 544 547.
7. A. Pich, L. Chiusa, and A. Formiconi et al. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder Cancer 95 2002 784 790.
8. M. Schulze, N. Stotz, and J. Rassweiler Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach J Endourol 21 2007 1533 1541.
9. Dalbagni G, Kaag M, Cronin A, Vora K, Bochner B, Donat SM, et al. Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma. BJU Int; 106, 1502-7.
10. H.W. Herr, G. Jakse, and J. Sheinfeld The T1 bladder tumor Semin Urol 8 1990 254 261.
11. Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol; 58, 185-90.
12. K.S. Cho, T.K. Hwang, and B.W. Kim et al. Differences in tumor characteristics and prognosis in newly diagnosed Ta, T1 urothelial carcinoma of bladder according to patient age Urology 73 2009 828 832 [832 e821].
13. L. Cheng, R.M. Neumann, A.L. Weaver, B.E. Spotts, and D.G. Bostwick Predicting cancer progression in patients with stage T1 bladder carcinoma J Clin Oncol 17 1999 3182 3187.
14. L. Cheng, A.L. Weaver, and D.G. Bostwick Predicting extravesical extension of bladder carcinoma: a novel method based on micrometer measurement of the depth of invasion in transurethral resection specimens Urology 55 2000 668 672.
15. Bertz S, Denzinger S, Otto W, Wieland WF, Stoehr R, Hofstaedter F, Hartmann A. Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series. Histopathology; 59, 722-32.
16. F. Brimo, C. Wu, N. Zeizafoun, S. Tanguay, A. Aprikian, and J.J. Mansure et al. Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion Hum Pathol 44 2013 95 102.
17. A. Lopez-Beltran, and L. Cheng Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance Pathology 35 2003 484 491.
18. M.N. van der Aa, G.J. van Leenders, and E.W. Steyerberg et al. A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation Hum Pathol 36 2005 981 986.
19. G.P. Paner, J.Y. Ro, E.M. Wojcik, G. Venkataraman, M.W. Datta, and M.B. Amin Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma Am J Surg Pathol 31 2007 1420 1429.
20. L. Cheng, A.L. Weaver, R.M. Neumann, B.G. Scherer, and D.G. Bostwick Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: a new proposal Cancer 86 1999 1035 1043.
21. S. Iida, T. Kondo, H. Kobayashi, Y. Hashimoto, N. Goya, and K. Tanabe Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience Int J Urol 16 2009 287 292.
22. Sakano S, Matsuyama H, Takai K, Yoshihiro S, Kamiryo Y, Shirataki S, Kaneda Y, Hashimoto O, Joko K, Suga A, Yamamoto M, Hayashida S, Baba Y, Aoki A. Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines. BJU Int 2011;107:1598-604.
23. M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Bohle, and J. Palou-Redorta et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Actas Urol Esp 36 2012 389 402.
24. H. Koga, K. Kuroiwa, A. Yamaguchi, Y. Osada, M. Tsuneyoshi, and S. Naito A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder J Urol 171 2004 153 157.
25. M.E. Nielsen, P.J. Bastian, and G.S. Palapattu et al. Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection Urology 70 2007 1091 1095.
26. Tahoun NS, Abdel Maksoud AM, Mohamed DB. Evaluation of the value of combined urine cytology and cystoscopy for follow-up of superficial transitional cell carcinoma of the urinary bladder. J Egypt Natl Canc Inst 2001;22:105-11.